VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.9500
-0.0150 (-1.55%)
At close: May 30, 2025, 4:00 PM
0.9949
+0.0449 (4.73%)
After-hours: May 30, 2025, 7:56 PM EDT
VYNE Therapeutics Stock Forecast
VYNE's stock price has decreased by -61.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for VYNE Therapeutics stock ranges from a low of $4.50 to a high of $8.00. The average analyst price target of $6.25 forecasts a 557.89% increase in the stock price over the next year.
Price Target: $6.25 (+557.89%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 25, 2025.
Analyst Ratings
The average analyst rating for VYNE Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.75 → $4.5 | Strong Buy | Maintains | $5.75 → $4.5 | +373.68% | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +505.26% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +505.26% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +505.26% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +505.26% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
204.00K
from 501.00K
Decreased by -59.28%
Revenue Next Year
204.00K
from 204.00K
EPS This Year
-1.26
from -0.94
EPS Next Year
-1.06
from -1.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 420,000 | 420,000 | n/a | |
| Avg | 204,000 | 204,000 | n/a | |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -16.2% | 105.9% | - | |
| Avg | -59.3% | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.23 | -0.79 | -0.85 |
| Avg | -1.26 | -1.06 | -0.83 |
| Low | -1.32 | -1.29 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.